{"Anagrelide":{"RelatedTo":"cGMP-inhibited 3',5'-cyclic phosphodiesterase A","Synonym":["Anagrelide HCL","Anagrelide Hydrochloride","BL-4162A","Agrylin"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00261","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00261","Definition":"Anagrelide is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). It also has been used in the treatment of chronic myeloid leukemia. (Wikipedia) Pharmacology: Anagrelide is a drug used for the treatment of essential thrombocytosis (ET; essential thrombocythemia). It works by inhibiting the maturation of megakaryocytes into platelets. The exact mechanism of action is unclear, although it is known to be a potent (IC50 "}}